Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-11-11 | 2022-04-21 | 149113 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-11-18 | 2021-12-23 | 149588 |
ACT REPAGLINIDE | 0.5MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149591 |
ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
ACT REPAGLINIDE | 2MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149606 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-11-18 | 2022-01-07 | 149609 |
TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2021-11-18 | 2022-02-17 | 149612 |
TEVA-ACYCLOVIR | 800MG | TABLET | Actual shortage | 2021-11-25 | 2021-11-25 | 149928 |
ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-11-25 | 2023-10-05 | 149931 |
ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2021-11-25 | 2022-02-05 | 149934 |
TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2021-11-25 | 2022-01-07 | 149937 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-11-25 | 2021-12-23 | 149945 |
TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-12-02 | 2023-01-26 | 150409 |
TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-12-17 | 2022-12-02 | 151381 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151419 |
ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2021-12-17 | 2022-05-26 | 151433 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2021-12-22 | 151445 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151456 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |